These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 9338017)

  • 1. Enhancement of retroviral production from packaging cell lines expressing the human immunodeficiency type 1 VPU gene.
    Kobinger GP; Mouland AJ; Lalonde JP; Forget J; Cohen EA
    Gene Ther; 1997 Aug; 4(8):868-74. PubMed ID: 9338017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human immunodeficiency virus type 1 VPU protein affects Sindbis virus glycoprotein processing and enhances membrane permeabilization.
    González ME; Carrasco L
    Virology; 2001 Jan; 279(1):201-9. PubMed ID: 11145902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suspension packaging cell lines for the simplified generation of T-cell receptor encoding retrovirus vector particles.
    Reuss S; Biese P; Cosset FL; Takeuchi Y; Uckert W
    Gene Ther; 2007 Apr; 14(7):595-603. PubMed ID: 17235289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of a high-titer packaging cell line for the production of retroviral vectors in suspension and serum-free media.
    Ghani K; Cottin S; Kamen A; Caruso M
    Gene Ther; 2007 Dec; 14(24):1705-11. PubMed ID: 17928873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substitution of the transmembrane domain of Vpu in simian-human immunodeficiency virus (SHIVKU1bMC33) with that of M2 of influenza A results in a virus that is sensitive to inhibitors of the M2 ion channel and is pathogenic for pig-tailed macaques.
    Hout DR; Gomez ML; Pacyniak E; Gomez LM; Fegley B; Mulcahy ER; Hill MS; Culley N; Pinson DM; Nothnick W; Powers MF; Wong SW; Stephens EB
    Virology; 2006 Jan; 344(2):541-59. PubMed ID: 16199074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An inducible packaging cell system for safe, efficient lentiviral vector production in the absence of HIV-1 accessory proteins.
    Pacchia AL; Adelson ME; Kaul M; Ron Y; Dougherty JP
    Virology; 2001 Mar; 282(1):77-86. PubMed ID: 11259192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The expression of full length Gp91-phox protein is associated with reduced amphotropic retroviral production.
    Bellantuono I; Lashford LS; Rafferty JA; Fairbairn LJ
    Haematologica; 2000 May; 85(5):451-7. PubMed ID: 10800158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fusion of the upstream vpu sequences to the env of simian human immunodeficiency virus (SHIV(KU-1bMC33)) results in the synthesis of two envelope precursor proteins, increased numbers of virus particles associated with the cell surface and is pathogenic for pig-tailed macaques.
    Hout DR; Gomez ML; Pacyniak E; Mulcahy ER; Gomez LM; Jackson M; Flick M; Fegley B; McCormick C; Wisdom BJ; Culley N; Pinson DM; Powers M; Wong SW; Stephens EB
    Virology; 2004 May; 323(1):91-107. PubMed ID: 15165822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The N-terminal matrix domain of HIV-1 Gag is sufficient but not necessary for viral protein U-mediated enhancement of particle release through a membrane-targeting mechanism.
    Deora A; Spearman P; Ratner L
    Virology; 2000 Apr; 269(2):305-12. PubMed ID: 10753709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The HIV-1 matrix domain of Gag is required for Vpu responsiveness during particle release.
    Lee YH; Schwartz MD; Panganiban AT
    Virology; 1997 Oct; 237(1):46-55. PubMed ID: 9344906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A retroviral packaging cell line for pseudotype vectors based on glioma-infiltrating progenitor cells.
    Fischer YH; Miletic H; Giroglou T; Litwak S; Stenzel W; Neumann H; von Laer D
    J Gene Med; 2007 May; 9(5):335-44. PubMed ID: 17474071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural and functional analysis of the membrane-spanning domain of the human immunodeficiency virus type 1 Vpu protein.
    Tiganos E; Friborg J; Allain B; Daniel NG; Yao XJ; Cohen EA
    Virology; 1998 Nov; 251(1):96-107. PubMed ID: 9813206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of medium sugar source on the production of retroviral vectors for gene therapy.
    Coroadinha AS; Ribeiro J; Roldão A; Cruz PE; Alves PM; Merten OW; Carrondo MJ
    Biotechnol Bioeng; 2006 May; 94(1):24-36. PubMed ID: 16514678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of transient expression system for retroviral vector production.
    Hotta A; Saito Y; Kyogoku K; Kawabe Y; Nishijima K; Kamihira M; Iijima S
    J Biosci Bioeng; 2006 Apr; 101(4):361-8. PubMed ID: 16716946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu.
    Neil SJ; Zang T; Bieniasz PD
    Nature; 2008 Jan; 451(7177):425-30. PubMed ID: 18200009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of a packaging cell line for prolonged large-scale production of high-titer HIV-1-based lentiviral vector.
    Ni Y; Sun S; Oparaocha I; Humeau L; Davis B; Cohen R; Binder G; Chang YN; Slepushkin V; Dropulic B
    J Gene Med; 2005 Jun; 7(6):818-34. PubMed ID: 15693055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of human immunodeficiency virus type 1 envelope glycoprotein YXXL endocytosis/polarization signal on viral accessory protein functions.
    Cervantes-Acosta G; Lodge R; Lemay G; Cohen EA
    J Hum Virol; 2001; 4(5):249-59. PubMed ID: 11907382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
    Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
    J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased gene transfer into human CD34+ progenitor cells using retroviral vectors produced by a canine packaging cell line.
    Bauer G; Sauter S; Ibanez C; Rice CR; Valdez P; Jolly D; Kohn DB
    Biol Blood Marrow Transplant; 1998; 4(3):119-27. PubMed ID: 9923409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of osteoclastic cell-cell fusion through retroviral vector packaging.
    Kondo T; Ikeda K; Matsuo K
    Bone; 2004 Nov; 35(5):1120-6. PubMed ID: 15542037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.